6-sulfatoxymelatonin has been researched along with Congenital Adrenal Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herer, P; Luboshitzky, R; Shen-Orr, Z | 1 |
| Hardoff, R; Luboshitzky, R; Qupti, G; Shen-Orr, Z | 1 |
| Herer, P; Ishay, A; Luboshitzky, R; Qupti, G; Shen-Orr, Z | 1 |
3 other study(ies) available for 6-sulfatoxymelatonin and Congenital Adrenal Hyperplasia
| Article | Year |
|---|---|
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome | 2004 |
Decreased melatonin secretion in a phenotypically male 46,XX patient with classic 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Hyperplasia, Congenital; Adult; Dehydroepiandrosterone Sulfate; Dexamethasone; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Dysgenesis, 46,XY; Hormone Replacement Therapy; Humans; Hydrocortisone; Luteinizing Hormone; Male; Melatonin; Oligospermia; Ovariectomy; Testosterone | 2000 |
Increased urinary 6-sulfatoxymelatonin excretion in women with non-classical steroid 21-hydroxylase deficiency.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Hyperplasia, Congenital; Adrenocorticotropic Hormone; Adult; Dehydroepiandrosterone Sulfate; Estradiol; Fasting; Female; Follicle Stimulating Hormone; Follicular Phase; Humans; Hyperandrogenism; Luteinizing Hormone; Melatonin; Mutation; Steroid 21-Hydroxylase; Testosterone | 2001 |